arsenic trioxide has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, T; Guo, P; Han, Y; Jiang, Y; Li, M; Li, Q; Luo, Y; Wang, Y; Wei, D; Yang, X; Zhao, J | 1 |
1 other study(ies) available for arsenic trioxide and Prostatic Neoplasms, Castration-Resistant
| Article | Year |
|---|---|
Enzalutamide combination with Arsenic trioxide suppresses the progression of castration-resistant prostate cancer.
Topics: Arsenic Trioxide; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Humans; Male; Nitriles; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen | 2023 |